Mineralocorticoid Receptor Antagonists [MoA] - N0000000139

Pharmacologic Class Information

Pharmacologic Code N0000000139
Pharmacologic Name Mineralocorticoid Receptor Antagonists
Pharmacologic Uses
  • non-steroidal mineralocorticoid receptor antagonist (MRA)
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Mineralocorticoid Receptor Antagonists

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Mineralocorticoid Receptor Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50419-540Kerendia Non-Proprietary Name: FinerenoneTablet, Film CoatedOralBayer Healthcare Pharmaceuticals Inc.ACTIVE
50419-541Kerendia Non-Proprietary Name: FinerenoneTablet, Film CoatedOralBayer Healthcare Pharmaceuticals Inc.ACTIVE